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Abstract A 122 nt uridine-rich sequence (URE) in the Na+/
glucose cotransporter (SGLT1) mRNA 3P-untranslated region is
critical for cAMP-dependent message stabilization. Its function
was investigated in LLC-PK1 cells stably expressing L-globin
reporter transcripts. Insertion of the SGLT1 URE downstream
from an unrelated destabilizing sequence, the c-fos ARE, evoked
cAMP-dependent message stabilization. Stabilization was
blocked by a substitution mutation within the SLGT1 URE.
These observations indicate that the SGLT1 URE is sufficient to
transmit cAMP-dependent, cis-dominant mRNA stabilization in
the presence of appropriate trans-acting factors and appears to
function independently of the nature of the destabilizing
domain. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
Key words: mRNA stability; cAMP; Glucose transporter
1. Introduction
The 3P-untranslated region (3P-UTR) of a wide variety of
genes contains highly conserved sequence elements of 100 nt
or more which have been implicated in regulation of message
stability and translation e⁄ciency [1,2]. For example, adenyl-
ate/uridylate-rich elements (AREs) found in many highly la-
bile mRNAs impart a potent destabilization when inserted
into the 3P-UTR of stable reporter messages [3,4]. Stability
regulation is mediated by the recognition of cis-acting signals
on mRNAs by RNA binding proteins but the molecular basis
for the speci¢city of this interaction and its regulation is
poorly understood. This process is regulated by cell signaling
pathways as a means to ¢ne-tune levels of gene expression in
response to changes in the cell environment or di¡erentiation
state [5].
Active glucose transport in kidney and intestine is mediated
by SGLT1 Na/glucose cotransporters in the apical mem-
brane. SGLT1 expression is di¡erentiation-dependent, up-
regulated after cyclic AMP elevation [6,7] and impaired in a
protein kinase A-de¢cient mutant [8]. Using deletion and mu-
tation analysis, we have recently identi¢ed a uridine-rich reg-
ulatory sequence element (URE) in the 3P-UTR of the Na/
glucose cotransporter SGLT1 mRNA which is critical for
cAMP-dependent stabilization of the message [9].
In the present study, we demonstrate that the SGLT1 URE
conveys cAMP-dependent message stabilization to a reporter
message even in the presence of the c-fos ARE, a potent,
unrelated destabilizing sequence. These observations indicate
that the SGLT1 URE is a dominant, cis-acting functional unit
and appears to act by a mechanism that is independent of the
nature of the destabilizing domain(s) contained in the mes-
sage.
2. Materials and methods
2.1. Materials
[K-32P]uridine triphosphate (3000 Ci/mmol) was obtained from ICN
(Costa Mesa, CA, USA). 3-Isobutyl-1-methylxanthine (IBMX) was
obtained from Sigma (St. Louis, MO, USA). The L-globin reporter
plasmid pTet-BBB, which expresses L-globin under the control of a
tetracycline-regulated promoter [10] and the plasmid T3 ARE fos [11]
were obtained from Dr. Ann-Bin Shyu, University of Texas, Houston
Medical School (Houston, TX, USA).
2.2. Cell culture
The porcine renal cell line LLC-PK1 clone G8 and its stably trans-
fected derivatives were cultured in a 1:1 mixture of Dulbecco’s modi-
¢ed Eagle’s medium and Ham’s F-12 supplemented with 10% fetal
bovine serum (HyClone, Logan, UT, USA), 2 mM glutamine, 0.37%
sodium bicarbonate, 1% penicillin-streptomycin (50 units/ml) and 24
mM HEPES, pH 7.0 as described previously [12], with other additions
as indicated.
2.3. Reporter plasmid construction
A gene coding for resistance to blasticidin (Bsd) was obtained by
digesting the vector pCMV/Bsd (Invitrogen) with SalI and XhoI. The
Bsd fragment was then ligated into the XhoI site located upstream of
the tetracycline promoter of pTet-BBB to form pTet-BBB/Bsd, which
contained the Bsd gene in the opposite orientation to the tetracycline
promoter. To test the in£uence of de¢ned sequence elements on the
stability of the L-globin message in vivo, test sequences were inserted
into a unique BglII site of pTet-BBB/Bsd located in the 3P-UTR of
L-globin. All SGLT1 nucleotide numbers refer to the pig SGLT1 se-
quence (accession no. M34044) [13]. Plasmid 122nt/Bam was prepared
from p3UTR2v7 [14] by digestion with StuI, religation in the presence
of excess BamHI linker followed by digestion with BamH1 to pro-
duced a 145 bp fragment containing SGLT1 nucleotides 2576^2697.
This was ligated into the BglII site of pTet-BBB/Bsd to create pTet-
BBB/Bsd+122 nt. Plasmid p122nt/Bam was used as template for site-
directed mutagenesis in order to construct p122 nt m2/Bam which
contained a TTCGG substitution at nucleotides 2622^2623, as de-
scribed previously [9]. This was digested with BamHI and the 122 nt
fragment was inserted into the BglII site in pTet-BBB/Bsd to create
plasmid pTet-BBB/Bsd+122 nt m2. The 211 bp c-fos ARE fragment
(nucleotides 3955^4165 of the human c-fos sequence) was excised from
T3 ARE fos by digestion with EcoRI and HindIII and then blunt-end
ligated into the above pTet-BBB/Bsd plasmids which had been pre-
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pared by digestion with PstI, ¢lled in using T4 DNA polymerase,
treated with calf intestinal phosphatase and then puri¢ed by agarose
electrophoresis, L-agarose digestion and ammonium sulfate precipita-
tion. The 211 bp c-fos ARE fragment was also inserted by blunt-end
ligation into the BglII site of pTet-BBB/Bsd. All constructs were veri-
¢ed by automated DNA sequencing.
2.4. Selection of double stable pTet-tTA/pTet-BBB LLC-PK1
transfectant cell lines
A clonal LLC-PK1 cell line LLC-TAK-B7 stably expressing the
tetracycline-regulated trans-activator (pTet-tTA) was selected by
G418 resistance [9] and then was stably transfected with the pTet-
BBB/Bsd constructs described above using the calcium phosphate
procedure we have described previously [9] followed by selection for
2 weeks in medium containing 500 ng/ml tetracycline, 500 Wg/ml G418
and 8 Wg/ml blasticidin.
2.5. Determination of chimeric mRNA decay rates
Stably transfected cell lines were grown to con£uence in medium
containing 30 ng/ml tetracycline, 8 Wg/ml blasticidin and 500 Wg/ml
G418. Then 1 mM IBMX was added to the indicated cultures for 96
h, with refeeding at 72 h. Cells were washed twice then given fresh
medium without tetracycline but containing 1 mM IBMX where in-
dicated. After a 15 h pulse of expression from the plasmid, transcrip-
tion was terminated by addition of 500 ng/ml tetracycline. At the
indicated times, monolayers were washed twice with ice-cold phos-
phate-bu¡ered saline and cytoplasmic RNA was extracted [15]. Sam-
ples of cytoplasmic RNA (10 Wg) were analyzed by Northern blot
using 32P-labeled riboprobes for rabbit L-globin and porcine glycer-
aldehyde phosphate dehydrogenase (GAPDH) mRNAs to determine
the kinetics of mRNA decay as we have described previously [9].
3. Results
3.1. Analysis of sequence domains which in£uence mRNA
stability
In order to monitor the rate of mRNA decay, we have used
the tetracycline-regulated promoter system to drive a tran-
scriptional burst of reporter mRNA expression in stably
transfected LLC-PK1 cell populations. The stable L-globin
message has been widely used as a reporter message to analyze
the e¡ects of destabilizing sequence domains within the 3P-
UTRs of various unstable mRNAs [3]. Plasmid pTet-BBB
encodes a L-globin minigene under control of the tetracy-
cline-regulated promoter (tet-OFF) [10,16]. Test sequences
are inserted into the unique BglII site located at the junction
of the translated and untranslated regions of the L-globin
gene. In the presence of the tetracycline-regulated transcrip-
tional activator (pTet-pTA), transcription of the chimeric L-
globin mRNA is switched on by removal of tetracycline from
the medium and rapidly switched o¡ following tetracycline
addition, permitting the analysis of mRNA decay character-
istics and half-life. This strategy o¡ers important advantages
over the use of transcription inhibitors since tetracycline does
not a¡ect mammalian cell physiology nor does it in£uence the
transcription or stability of endogenous cellular mRNAs. The
use of stable transfectants avoids non-physiological side ef-
fects and variations in expression associated with transient
transfection methods. Furthermore, expression can be moni-
tored in con£uent cell lines whereas transient transfection re-
quires subcon£uent, actively dividing cells.
LLC-PK1 cell populations stably expressing both the tetra-
cycline-regulated trans-activator pTet-pTA and the indicated
pTet-BBB/Bsd L-globin reporter plasmids, were used for anal-
ysis of mRNA decay. Uncloned populations of resistant cells
were used in order to minimize e¡ects due to clonal di¡erences
in integration of the plasmid. Analysis of the kinetics of ex-
pression after tetracycline removal indicated that after a 3 h
lag, expression levels increased linearly for 16 h, reaching 50^
60% of maximum after 15 h (data not shown). In the presence
study, an expression period of 15 h was used in order to
achieve reporter mRNA levels su⁄cient for analysis of decay.
3.2. A destabilizing domain and a regulatory cAMP-dependent
stabilizing domain map within a 122 nt sequence
(nucleotides 2576^2697)
Previously, we have identi¢ed a 435 nt uridine-rich domain
(URE) within the 3P-untranslated region of the Na/glucose
cotransporter SGLT1 mRNA that conveys cAMP-dependent
message stabilization to a reporter L-globin message assayed
in transient transfectants [9]. In the absence of cAMP eleva-
tion, this sequence has a destabilizing e¡ect. A UUCGG
substitution mutation at nucleotides 2262^2263 within this
domain resulted in loss of cAMP-dependent stabilization
and also reduced protein binding to this sequence. Protein
binding sites were localized to a 122 nt uridine-rich sequence
within the 435 nt segment [9] but e¡ects of the 122 nt sequence
on stability have not previously been tested. Results shown in
Figs. 1 and 2 indicate that L-globin transcripts bearing either
the wild-type 122 nt SGLT1 sequence or the mutant 122 nt
m2 sequence containing the UUCGG substitution mutation
at nucleotides 2262^2263 decayed with similar rates in control,
untreated cultures (t1=2 = 5.5 h). These decay rates signi¢cantly
exceeded those of reporter transcripts lacking these sequences
(t1=2s 12 h), indicating the presence of destabilizing sequen-
ces. After treatment with the phosphodiesterase inhibitor
IBMX in order to elevate cyclic AMP levels, transcripts bear-
ing the wild-type 122 nt sequence became stable (t1=2s 13 h),
with over 90% of the mRNA remaining at 10 h after inhibi-
tion of transcription. Mutant transcripts (122 nt m2) were
only minimally stabilized after IBMX treatment, manifest as
an increased lag period of 3 h before initiation of decay of the
mRNA body. The decay phase exhibited a half-life of 5.7 h,
unchanged from that of control, untreated cultures.
3.3. cis-Dominance of the cAMP-dependent 122 nt SGLT1
regulatory domain in the presence of the c-fos ARE
sequence
We next asked whether the cAMP-dependent stabilizing
function of the 122 nt regulatory domain was speci¢c for
the endogenous destabilizing activity present within this se-
quence or whether it could exert its e¡ects on a di¡erent
category of destabilization element. For this purpose, we
chose the 211 nt c-fos ARE as the test sequence. The c-fos
ARE is a potent destabilizing element found in the 3P-UTRs
of a variety of highly labile mRNAs [3,15]. Several key se-
quence features responsible for its destabilizing function have
been de¢ned [17,18] and it behaves as a functional destabiliz-
ing element where inserted into a variety of reporter con-
structs [10,19].
We ¢rst demonstrated that the c-fos ARE promoted desta-
bilization of the reporter L-globin transcript in stably trans-
fected LLC-PK1 cells (Figs. 1, 2). As expected, ARE-bearing
transcripts were rapidly degraded, with a half-life of 3.2 h, in
the absence of IBMX. After 10 h, only 25% of the initial
transcripts remained. Surprisingly, IBMX treatment led to
partial stabilization of ARE-mediated decay, with 60% of
transcripts remaining after 10 h. Stabilization of c-fos ARE-
containing messages by cAMP elevation has not been previ-
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ously described, although cAMP elevation has been reported
to regulate decay of messages bearing similar AU-rich motifs
[20,21].
Next, the potential interplay between the c-fos ARE and the
122 nt SGLT1 regulatory domain was tested using stable
transfectants expressing reporter L-globin transcripts bearing
both the c-fos ARE and the wild-type and mutant 122 nt
SGLT1 regulatory domains (Figs. 1, 2). The 211 nt c-fos
ARE sequence [22] was placed at 14 nt upstream of the
SGLT1 122 nt sequence. In the absence of IBMX, both c-
fos ARE/SGLT1 122 nt and c-fos ARE/SGLT1 122 nt m2
L-globin chimeric transcripts decayed with the same half-life
of 6.2 h, indicating that the UUCGG substitution mutation
in the 122 nt m2 sequence did not in£uence destabilization.
This decay rate was approximately 2-fold slower than that of
transcripts bearing the c-fos ARE alone under these condi-
tions but similar to that of transcripts bearing the 122 nt se-
quence. In IBMX-treated cultures, reporter transcripts bear-
ing the c-fos ARE/122 nt wild-type sequence exhibited a
pronounced stabilization, with over 80% of the transcripts
Fig. 1. Cyclic AMP-dependent stabilization of L-globin mRNA by the 122 nt SGLT1 regulatory domain in the presence of the c-fos ARE is
decreased by mutation in a critical uridine pentamer within the SGLT1 URE. Stably transfected LLC-PK1 cell lines exhibiting tetracycline-
regulated expression of chimeric L-globin mRNAs containing the indicated insert in the 3P-UTR were analyzed for L-globin mRNA decay after
growth in the presence or absence of 1 mM IBMX. Blots were simultaneously hybridized with riboprobes for GAPDH and L-globin mRNA.
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remaining after 10 h. By contrast, reporter transcripts bearing
the c-fos ARE/122 nt m2 sequence exhibited no increase in
stability after IBMX treatment. Even the partial cAMP-de-
pendent stabilization observed in transcripts containing the
c-fos ARE alone was not observed for the chimeric c-fos
ARE/SGLT1 122 nt m2 sequence. These observations indicate
that the cAMP-dependent mRNA stabilizing activity associ-
ated with the 122 nt SGLT1 URE is functionally dominant in
the presence of the c-fos ARE. The speci¢c contribution of
this element is demonstrated by the observation that the sub-
stitution mutation within the 122 nt sequence completely
blocks cAMP-mediated stabilization.
4. Discussion
In the present study, we demonstrate using stable transfec-
tants of LLC-PK1 cells that the SGLT1 URE conveys cAMP-
regulated cytoplasmic message stabilization to chimeric tran-
scripts containing an unrelated destabilizing sequence, the
well-characterized c-fos ARE. Our results also indicate that
a potent destabilizing domain and a cAMP-dependent stabi-
lizing domain reside in close proximity within a 122 nt se-
quence domain in the 3P-UTR of the SGLT1 message. Close
proximity between destabilizing and cAMP-dependent stabi-
lizing domains has also been described in the case of lactate
dehydrogenase-A subunit mRNA, which contains both activ-
ities within a 22 nt sequence in the 3P-UTR [23]. A close
proximity between destabilizing and stabilizing domains has
also been described in the case of the c-fos ARE [22].
Analysis of 3P-UTR sequence elements implicated in
cAMP-dependent mRNA stabilization in various messages
has not revealed a consensus sequence motif which is gener-
ally characteristic of cAMP-dependent regulatory domains,
although most described to date are enriched in uridine resi-
dues. In the case of porcine SGLT1, the minimal 12 nt bind-
ing site for a 38 kDa protein implicated in stability regulation
is AUUUUUGGUUAA [9]. An RNA transcript based on the
homologous human SGLT1 sequence containing the pentame-
ric uridine motif also recognized the same binding activity in
LLC-PK1 cell extracts, indicating that human SGLT1 may be
regulated by a similar mechanism [9]. The cAMP-dependent
stabilizing region in the lactate dehydrogenase-A 3P-UTR was
identi¢ed as AUAUUUUCUGUAUUAUAUGUGU [23].
Agonist destabilization of hamster L-adrenergic receptor
mRNA was associated with a 20 nt AU-rich sequence [21]
containing a critical AUUUUA motif which can tolerate the
loss of one or gain of several uridine residues as determined
by mutation and by comparison of the homologous region in
di¡erent species [24]. By contrast, cAMP destabilization of
type-1 plasminogen activator-inhibitor mRNA was associated
with a predominantly A-rich sequence [25].
The mechanism of cAMP-dependent e¡ects on message
stability is not understood. Proteins which bind the SGLT1
URE sequence are most abundant in the nucleus but also
found in the cytoplasm [9]. Stability-enhancing proteins may
¢rst bind the URE domain in the nucleus after protein kinase
A activation and protein phosphorylation. They would then
accompany the message into the cytoplasm, acting to block or
displace destabilizing factors such as ribonucleases. Protein
phosphorylation is required for protein binding to the
SGLT1 URE, suggesting the involvement of a regulatory cas-
cade [9,14].
E¡orts are currently underway to identify the RNA binding
proteins which interact with the SGLT1 URE to increase
SGLT1 mRNA stability and the signaling pathways which
regulate this interaction. These studies will provide insight
into the series of events leading to increased active glucose
resorption in kidney and intestine and increased blood glucose
levels [26] following activation of protein kinase A.
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